Tuesday, May 02, 2023 1:29:52 AM
I completely agree with you. It wouldn't surprise me if LP actually has an informal agreement for a buyout, but I'd be willing to bet the price is somewhere over $20 billion and in order to make it happen I believe that the share price ought to be at least half of what they'll be paying. If not that high, they'll need to reveal something dynamic that convinces the shareholders in the acquiring BP that they're not overpaying, something they were prevented from announcing before the buyout agreement was announced.
Such an agreement would be formalized as NWBO approached whatever was agreed to, it could be the initial approval, or the approval of all four regulators, something in between, or perhaps the FDA specified. It may, or may not require the approval of the Eden unit. Perhaps it could even be revenue reaching a specific level. In short, the goal could be achievable this year, or could take at least a couple years to achieve. I don't believe anything is absolutely firm, LP's to smart not to leave some wiggle room, especially if in her opinion the price she originally agreed on is too low for what the buyer will be getting.
Gary
Such an agreement would be formalized as NWBO approached whatever was agreed to, it could be the initial approval, or the approval of all four regulators, something in between, or perhaps the FDA specified. It may, or may not require the approval of the Eden unit. Perhaps it could even be revenue reaching a specific level. In short, the goal could be achievable this year, or could take at least a couple years to achieve. I don't believe anything is absolutely firm, LP's to smart not to leave some wiggle room, especially if in her opinion the price she originally agreed on is too low for what the buyer will be getting.
Gary
Bullish
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
